Neurodegen SRL
Neurodegen reported total assets of €2.28m at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026).
By total assets for 2025, Neurodegen ranks among the 1,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Neurodegen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +54 % Total assets +27 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Neurodegen's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Neurodegen's financial analysis
- Solvency74.4%sector median: 55.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Neurodegen
Neurodegen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.829.306
- VAT number
- BE0479829306
- Peppol
- Registered · 0208:0479829306 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Mar 2003
- Registered office
- 3000 Leuven
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Neurodegen (SRL) has been based in Leuven since 2003, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 265,714 € and equity of €1.69m; its revenue is not published. Its solvency stands at 74.4%, above the median of its sector (55.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Neurodegen
Companies in the same business, of comparable size and area, outside its group.
- Lesire Other business support service activities n.e.c. Leuven · balance sheet €2.02m
- Diercxsens Investments & Advisory Other business support service activities n.e.c. Antwerp · balance sheet €2.27m
- Food Projects Other business support service activities n.e.c. Lille · balance sheet €2.29m
- manam Other business support service activities n.e.c. Heusden-Zolder · balance sheet €2.29m
- S & A Consult Other business support service activities n.e.c. Ichtegem · balance sheet €2.24m
- Cogitare Other business support service activities n.e.c. Keerbergen · balance sheet €2.21m
- Roodhuis Other business support service activities n.e.c. Brussels · balance sheet €2.20m
- Verbo Quercus Other business support service activities n.e.c. Mortsel · balance sheet €2.37m
Frequently asked questions about Neurodegen
What is the revenue of Neurodegen?
Neurodegen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Neurodegen?
In Belgium, the VAT number is the company number prefixed with BE: BE0479829306 for Neurodegen, if the company is VAT-registered. Its company number (CBE) is 0479.829.306.
Where is the registered office of Neurodegen?
According to the CBE register, the registered office of Neurodegen is in 3000 Leuven.
What is the equity of Neurodegen?
At the close of the 2025 financial year, the equity of Neurodegen amounts to 1,693,979 €, a solvency of 74.4% of total assets.
Who manages Neurodegen?
The register lists 2 active mandates at Neurodegen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Neurodegen within its sector?
By total assets for 2025, Neurodegen ranks among the 1,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year.
The full file of Neurodegen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →